0001011438-12-000197.txt : 20120504 0001011438-12-000197.hdr.sgml : 20120504 20120504133043 ACCESSION NUMBER: 0001011438-12-000197 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120504 DATE AS OF CHANGE: 20120504 GROUP MEMBERS: ROSS MARGOLIES SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Symmetry Medical Inc. CENTRAL INDEX KEY: 0001292055 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 351996126 STATE OF INCORPORATION: DE FISCAL YEAR END: 0101 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-80511 FILM NUMBER: 12813312 BUSINESS ADDRESS: STREET 1: 3724 N STATE ROAD 15 CITY: WARSAW STATE: IN ZIP: 46582 BUSINESS PHONE: 574-268-2252 MAIL ADDRESS: STREET 1: 3724 N STATE ROAD 15 CITY: WARSAW STATE: IN ZIP: 46582 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: STELLIAM INVESTMENT MANAGEMENT, LP CENTRAL INDEX KEY: 0001427165 IRS NUMBER: 205834929 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 12 EAST 49TH STREET, 22ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (212) 490-6700 MAIL ADDRESS: STREET 1: 12 EAST 49TH STREET, 22ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 SC 13G 1 form_sc13g-symmetry.htm form_sc13g-symmetry.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No.  )*

SYMMETRY MEDICAL INC.
(Name of Issuer)

Common Stock, Par Value $0.001 Per Share
(Title of Class of Securities)

871546206
(CUSIP Number)

April 26, 2012
(Date of Event which Requires Filing
of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:


[   ]
 Rule 13d-1(b)
[X]
 Rule 13d-1(c)
[   ]
 Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Continued on following pages
Page 1 of 9 Pages
Exhibit Index: Page 8

 
 
 

CUSIP NO.  871546206
Page 2 of 9 Pages


1.
Names of Reporting Persons

STELLIAM INVESTMENT MANAGEMENT, LP


2.
Check the Appropriate Box If a Member of a Group (See Instructions)
a.  
[   ]
b.  
[   ]

3.
SEC Use Only

4.
Citizenship or Place of Organization

DELAWARE

 
5.
Sole Voting Power
Number of
Shares
  
1,850,000
Beneficially
Owned By
Each
6.
Shared Voting Power
0
Reporting
Person
With
7.
Sole Dispositive Power
1,850,000
 
8.
Shared Dispositive Power
   
0


9.
Aggregate Amount Beneficially Owned by Each Reporting Person

1,850,000

10.
Check Box If the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

[   ]

11.
Percent of Class Represented By Amount in Row (9)


5.06%

12.
Type of Reporting Person (See Instructions)

PN, IA




 
 
 

CUSIP NO.  871546206
Page 3 of 9 Pages


1.
Names of Reporting Persons

ROSS MARGOLIES


2.
Check the Appropriate Box If a Member of a Group (See Instructions)
a.  
[   ]
b.  
[   ]

3.
SEC Use Only

4.
Citizenship or Place of Organization

UNITED STATES

 
5.
Sole Voting Power
Number of
Shares
  
1,850,000
Beneficially
Owned By
Each
6.
Shared Voting Power
0
Reporting
Person
With
7.
Sole Dispositive Power
1,850,000
 
8.
Shared Dispositive Power
   
0

9.
Aggregate Amount Beneficially Owned by Each Reporting Person

1,850,000

10.
Check Box If the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

[   ]

11.
Percent of Class Represented By Amount in Row (9)

5.06%

12.
Type of Reporting Person (See Instructions)

IN; IA

 
 
 

CUSIP NO.  871546206
Page 4 of 9 Pages


Item 1(a).
Name of Issuer:
   
 
Symmetry Medical Inc. (the "Issuer").
   
Item 1(b).
Address of the Issuer's Principal Executive Offices:
   
 
3724 North State Road 15
 
Warsaw, Indiana 46582
   
Item 2(a).
Name of Person Filing
   
 
The Statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”):

i)  
Stelliam Investment Management, LP (“Stelliam Investment Management”); and

ii)  
Ross Margolies (“Mr. Margolies”).

 
This statement relates to Shares (as defined herein) held for the account of Stelliam Master Fund, L.P., a Cayman Islands exempted limited partnership (the “Master Fund”), Stelliam Master Long Fund, L.P., a Cayman Islands exempted limited partnership (the “Long Fund”), and a certain other fund for which Stelliam Investment Management provides investment management or investment advice (the “Other Fund” and together with the Master Fund and the Long Fund, the “Funds”).  Stelliam Investment Management serves as investment manager of the Funds and Mr. Margolies is the managing member of Stelliam Investment Management’s general partner.  Each of Stelliam Investment Management and Mr. Margolies, in the capacities set forth above, may be deemed to be the beneficial owner of Shares held for the account of the Funds.

Item 2(b).
Address of Principal Business Office or, if None, Residence:
   
 
The address and principal business office of each of the Reporting Persons is 12 East 49th Street, 22nd Floor, New York, New York 10017.

Item 2(c).
Citizenship:

i)  
Stelliam Investment Management is a Delaware limited partnership; and

ii)  
Mr. Margolies is a United States citizen.

Item 2(d).
Title of Class of Securities:
 
 
Common Stock, Par Value $0.001 per share (the “Shares”).
 
Item 2(e).
CUSIP Number:
   
 
871546206

 
 
 

CUSIP NO.  871546206
Page 5 of 9 Pages


Item 3.
If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
 
 
This Item 3 is not applicable.
 
Item 4.
Ownership:
   
Item 4(a).
Amount Beneficially Owned:
   
 
As of the date hereof, each of the Reporting Persons may be deemed to be the beneficial owner of the following number of Shares:
   
 
(i) Stelliam Investment Management may be deemed to be the beneficial owner of 1,850,000 Shares held directly by the Funds.
   
 
(ii) Mr. Margolies may be deemed to be the beneficial owner of 1,850,000 Shares.
   
Item 4(b).
Percent of Class:
   
 
(i) Stelliam Investment Management may be deemed to be the beneficial owner of approximately 5.06% of the total number of Shares outstanding (based upon information provided by the Issuer on Form 10-K/A filed April 18, 2012, there were 36,575,331 Shares outstanding as of March 12, 2012).
   
 
(ii) Mr. Margolies may be deemed to be the beneficial owner of approximately 5.06% of the total number of Shares outstanding as described herein.
   
Item 4(c).
Number of shares as to which such person has:
   

 
Stelliam Investment Management
 
(i)
Sole power to vote or direct the vote
1,850,000
 
(ii)
Shared power to vote or to direct the vote
0
 
(iii)
Sole power to dispose or to direct the disposition of
1,850,000
 
(iv)
Shared power to dispose or to direct the disposition of
0

 
Mr. Margolies
 
(i)
Sole power to vote or direct the vote
1,850,000
 
(ii)
Shared power to vote or to direct the vote
0
 
(iii)
Sole power to dispose or to direct the disposition of
1,850,000
 
(iv)
Shared power to dispose or to direct the disposition of
0

 
 
 

CUSIP NO.  871546206
Page 6 of 9 Pages


Item 5.
Ownership of Five Percent or Less of a Class:
   
 
This Item 5 is not applicable.
   
Item 6.
Ownership of More than Five Percent on Behalf of Another Person:
   
 
The partners of the Funds that participate in the investment in the Issuer have the right to participate in the receipt of dividends from, or proceeds from the sale of, the Shares held by the Funds pro rata in accordance with their respective ownership interests in the Funds.
   
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:
   
 
This Item 7 is not applicable.
   
Item 8.
Identification and Classification of Members of the Group:
   
 
This Item 8 is not applicable.
   
Item 9.
Notice of Dissolution of Group:
   
 
This Item 9 is not applicable.
   
Item 10.
Certification:

 
By signing below each of the Reporting Persons certifies that, to the best of such person's knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.


 
 
 

CUSIP NO.  871546206
Page 7 of 9 Pages


SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.




Date:  May 4, 2012
STELLIAM INVESTMENT MANAGEMENT, LP
   
 
By:         /s/ Gregg Kudisch
 
Gregg Kudisch
 
Chief Financial Officer

Date:  May 4, 2012
ROSS MARGOLIES
   
 
By:         /s/ Ross Margolies
   
   
   

 
 
 

CUSIP NO.  871546206
Page 8 of 9 Pages


EXHIBIT INDEX

   
Page No.
A.
Joint Filing Agreement, dated as of May 4, 2012, between Stelliam Investment Management LP and Ross Margolies
 
9
 

 
 
 

CUSIP NO.  871546206
Page 9 of 9 Pages


EXHIBIT A

JOINT FILING AGREEMENT

The undersigned hereby agree that the Schedule 13G with respect to the Common Stock, Par Value $0.001 per share, of Symmetry Medical Inc., dated as of May 4, 2012, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.



Date:  May 4, 2012
STELLIAM INVESTMENT MANAGEMENT, LP
   
 
By:         /s/ Gregg Kudisch
 
Gregg Kudisch
 
Chief Financial Officer

Date:  May 4, 2012
ROSS MARGOLIES
   
 
By:         /s/ Ross Margolies